From Numbness to Comfort: Pioneering Pediatric Anesthesia Reversal with Photobiomodulation Authors: Priya Meharwade, Priyanka Mothi, Kirthi S Honakeri, Adithya Sanjeev, Helen R Baby, Anand Tavargeri Published: 2025 ABSTRACT AbstractAdministering local anesthesia (LA) in children is a critical aspect of minimizing pain and anxiety during medical and dental procedures. However, the prolonged postanesthetic numbness often poses unique challenges in children, leading to several problems. This review highlights pediatric anesthesia management by investigating the application of photobiomodulation (PBM) for the efficient and safe reversal of LA effects. PBM, a low-level laser therapy (LLLT), has gained momentum of late for its therapeutic potential in various dental applications. Emphasizing the safety and noninvasiveness of PBM, the optimal parameters, including wavelength, energy density, and duration, tailored to the unique requirements of pediatric patients, are taken into consideration. Furthermore, the psychosocial aspects of pediatric anesthesia reversal using PBM, considering the potential impact on anxiety levels, postprocedural discomfort, and overall patient cooperation, are addressed. This review explores the promising landscape of utilizing PBM to revolutionize pediatric postanesthetic care, contributing to a paradigm shift in recovery of even the youngest members of our patient population.How to cite this articleMeharwade P, Mothi P, Honakeri KS, et al. From Numbness to Comfort: Pioneering Pediatric Anesthesia Reversal with Photobiomodulation. Int J Clin Pediatr Dent 2025;18(12):1526–1529.Keywords: Light amplification by stimulated emission of radiation, Local anesthesia, Pain, Pediatric anesthesia, Photobiomodulation therapy, Reversal Introduction A trip to the dentist can be a daunting experience for anyone, but for children, it often evokes even greater apprehension. The anticipation of any pain and suffering during dental procedures can lead to restlessness, potentially causing distressing consequences both in the present and future appointments. To alleviate anxiety and pain and ensure a more comfortable dental experience, local anesthesia (LA) has become a cornerstone of pediatric dentistry.1 Administered to numb specific areas of the mouth, LA effectively blocks pain signals, allowing dental procedures to be performed with minimal discomfort. However, despite its benefits, the administration of LA in children is not without its challenges. The action of LA has been shown to last roughly 3–5 hours, which is actually more than needed.2 This extended effect of the same is said to be around 15%, even after the dental treatment is completed.3 This inadvertent long duration of anesthesia, longer than required, has led to children experiencing numbness, resulting in many problems such as biting of the lip, tongue, and cheek, speech impairment, and even difficulties in swallowing, eating, and drinking.4,5 Patients often refuse to visit dentists due to these factors. What are the ways in which the level of these injuries can be mitigated? One such method is the use of phentolamine mesylate, which is the advocate for LA reversal (vasoconstrictor-mediated antagonist).6,7 The use of these drugs reduces blood vessel contraction and increases vascularity to the injection site, allowing the anesthetic agent to be eliminated more quickly.7 But pediatric patients often experience anxiety when facing these invasive procedures, prompting the need for a viable alternative. Seraj et al., in their study, identified photobiomodulation (PBM) as an alternative mode of reversal.8 PBM treatment operates in the visible (400–700 nm) and near-infrared (700–1100 nm) range of nonionizing electromagnetic light spectrum.9 These include light amplification by stimulated emission of radiation (LASER), light-emitting diodes (LEDs), and/or broadband light.10 Mechanism of Photobiomodulation In our body, we have melanin and hemoglobin; these are called chromophores, which are molecular photoacceptors. These photoacceptors are responsible for absorbing low-power visible light photons. An enzyme called cytochrome c oxidase is present in the inner mitochondrial membrane of chromophores. This enzyme absorbs red light (600–810 nm) and it displaces nitric oxide (NO), thereby activating the enzyme, and a proton gradient is created. As a consequence, the levels of Calcium (Ca2+), reactive oxygen species (ROS), and ATP are increased. On the other hand, application of infrared light (800–1064 nm) activates the light-sensitive ion channels, thereby resulting in increased levels of Ca2+. This Ca2+ combines with ROS and cyclic AMP to increase proliferation, migration, and differentiation of cells (Fig. 1).11 Photobiomodulation: underlying mechanism & clinical application11 Mechanism of Photobiomodulation in the Reversal of Local Anesthesia in Soft Tissue Light amplification by stimulated emission of radiation stimulates the production of free nitric oxide, which is considered a powerful vasodilator. This increases the microcirculation, thereby increasing the elimination of LA. This was concluded based on the outcomes of the study conducted on Yucatan microswine, where percutaneous delivery of low-level laser had a positive effect on the relaxation of vascular smooth muscle by reversing histamine-induced spasm in atherosclerotic Yucatan microswine.12 Furthermore, studies by Maegawa et al. and Kubota concluded that use of an 830-nm diode laser for PBM led to an increase in the blood flow in a rat model.13,14 Keeping this mechanism of action, Seraj et al. assessed PBM therapy by an 810-nm diode laser on the reversal of LA on the soft tissues in pediatric dentistry.8 The study was conducted on 34 children aged between 4 and 8 years old who received infiltration at both the right and left sides of the mandible (Fig. 2). Seraj et al. study design8 The palpation technique was used to assess the degree of anesthesia every 15 minutes. This study found that PBM therapy using an 810-nm diode laser reduced the reversal duration of the LA on the soft tissues by 43 minutes compared to individuals who did not use PBM. We will further review one more study by Annu et al., which compared the effect of PBM therapy at two different wavelengths of 660 and 810 nm on the soft tissue LA reversal in pediatric dentistry: an in vivo study (Fig. 3).9 Layout of the study design9 After every 15 minutes, pin prick and palpation tests were used to check the reversal of LA on the soft tissue. The LASER irradiation cycle was then continued until the soft tissue LA was reversed. The study's findings showed that using 810 nm wavelength PBM and 660 nm wavelength laser irradiation significantly shortened the mean soft tissue local anesthetic reversal time by 55.5 minutes (27.6%) and 69 minutes (34.7%), respectively. PBM with a wavelength of 660 nm was more successful in lowering the mean duration of soft tissue LA reversal, and hence can be thought of as a reversal agent for soft tissue anesthesia in children. Conclusion Photobiomodulation shows potential as a beneficial treatment in reversing soft tissue LA. Its ability to accelerate recovery, reduce pain, and promote healing makes it an attractive option for enhancing patient outcomes. This alternative option is a safe, nonintrusive, less anxiety-provoking, and pain-free technique, especially in children, and avoids the need for further injections compared with phentolamine mesylate. It helps in reducing the occurrence of postoperative self-inflicted soft tissue injuries in pediatric patients. Also, it increases patient compliance and further visits to pediatric dentists. However, the clinical applicability of PBM is currently limited by factors such as variability in treatment protocols, cost, and the need for further research to establish standardized guidelines. Further, the implementation of PBM in reversal of anesthesia has the potential to achieve remarkable results. Orcid Priya Meharwade https://orcid.org/0000-0003-2328-1936 Priyanka Mothi https://orcid.org/0000-0002-7417-1529 Kirthi S Honakeri https://orcid.org/0009-0000-7213-1323 Footnotes Source of support: Nil Conflict of interest: None References